Consistent with our findings, CDK6 overexpression in PLC/PRF/5 cells significantly enhanced tumorigenicity with an increase in the estimated cancer stem cell (CSC) frequency (Fig. 2c, Supplementary Table 2). The gene discussed is HSPG2; the disease is cancer.